Large-scale randomised controlled trials, including the STEP 1 trial (Wilding et al., NEJM 2021) for semaglutide 2.4 mg, have demonstrated clinically meaningful and sustained weight loss in adults with obesity or overweight with weight-related comorbidities
Epub 2024 Jun 14 PMID: 38872502
Investigators administered BPC-157 by three routes intraperitoneal injection, oral administration in drinking water, and topical application as a thin cream layer with assessment over a 90-day post-injury period
In some cases, additional tests such as blood tests or biopsies may be required to rule out other conditions
This formulation is supplied to support controlled laboratory handling, consistent preparation, and reproducibility across analytical and non-clinical research workflows
Price range: $34.59 through $50.74 All products are for laboratory research purposes only